Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Unknown 2Terminated 1Suspended 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Other 1Classical hematology 1

Conditions

Pain 11Neoplasms 5Cancer Pain 4Pain, Postoperative 2Malignant Female Reproductive System Neoplasm 2Hematologic Neoplasms 2Emergencies 2Agnosia 2Uterine Cervical Neoplasms 1Tumor Surgery 1Sarcoma 1Rectal Neoplasms 1Pulmonary Nodule 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Pain, Intractable 1Ovarian Neoplasms 1Neuralgia 1Neoplasm Metastasis 1Mucositis 1Lymphoma, Follicular 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Intraoperative Complications 1Ileus 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Duodenal Neoplasms 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neoplasms × Hydromorphone × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

NCT03564548 2021-07-28

REBORN

Tetra Bio-Pharma

Phase 2 Unknown
20 enrolled
Tumor-Agnostic

Neoplasms

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Completed
150 enrolled

Cancer Pain, Neoplasms, Neuralgia

NCT02084355 2014-03-12

Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain

Gyeongsang National University Hospital

Phase 3 Unknown
136 enrolled

Neoplasms, Pain

NCT01648699 2013-10-11

Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain

Janssen Pharmaceutica

Phase 4 Terminated
20 enrolled 9 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡